ロード中...
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
Research suggests that Alzheimer disease (AD) pathophysiology begins prior to the clinical expression of the disease and that biomarker measures may provide direct evidence of this process. As a result, it may be possible to uncouple the diagnosis of AD from the clinical expression of the disease. T...
保存先:
| 出版年: | Neurology |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Lippincott Williams & Wilkins
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4561233/ https://ncbi.nlm.nih.gov/pubmed/21917767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318232ac1a |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|